Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Indo AminesNSE:INDOAMIN +1.66%92 ROC (Joel Greenblatt) % is 28.69% as of Jun. 2026, which is 42% above its 10-year median of 20.14. GuruFocus rates NSE:INDOAMIN with a GF Score™ of 92/100 and a GF Value™ of ₹157.09 (Modestly Undervalued). The stock has 1 warning sign investors should review. Among 1,609 Chemicals companies, Indo Amines ranks better than 75.2% on this metric.
Joel Greenblatt defined Return on Capital differently in his book The Little Book That Still Beats the Market (Little Books. Big Profits). He defines ROC (Joel Greenblatt) % as EBIT divided by the total of Property, Plant and Equipment and net working capital. Indo Amines's annualized ROC (Joel Greenblatt) % for the quarter that ended in Jun. 2026 was 28.69%.
The historical rank and industry rank for Indo Amines's ROC (Joel Greenblatt) % or its related term are showing as below:
NSE:INDOAMIN'
s ROC (Joel Greenblatt) % Range Over the Past 10 Years
Min: 12.68 Med: 20.14 Max: 39.37
Current: 21.68
During the past 13 years, Indo Amines's highest ROC (Joel Greenblatt) % was 39.37%. The lowest was 12.68%. And the median was 20.14%.
NSE:INDOAMIN's ROC (Joel Greenblatt) % is ranked better than 75.2% of 1609
companies
in the Chemicals industry
Industry Median: 10.55
vs NSE:INDOAMIN: 21.68
Indo Amines's 5-Year average Growth Rate of ROC (Joel Greenblatt) % was 1.80% per year.
The way Joel Greenblatt defines Return on Capital is a more accurate measure of how efficiently the company generates returns onthe capital actually invested in the business. EBIT is used instead of net income because the tax and interest payment may be affected by factors other than the core business operation. Intangible assets are not included in the calculation because they don't need to be replaced.
Indo Amines ROC (Joel Greenblatt) % Historical Data
* Premium members only.
The historical data trend for Indo Amines's ROC (Joel Greenblatt) % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
NSE:INDOAMIN vs DOW: ROC (Joel Greenblatt) % Comparison
For the Chemicals subindustry, Indo Amines's ROC (Joel Greenblatt) %, along with its competitors' market caps and ROC (Joel Greenblatt) % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Indo Amines ROC (Joel Greenblatt) % vs Chemicals Industry
For the Chemicals industry and Basic Materials sector, Indo Amines's ROC (Joel Greenblatt) % distribution charts can be found below:
* The bar in red indicates where Indo Amines's ROC (Joel Greenblatt) % falls into.
Joel Greenblatt defined Return on Capital differently in his book The Little Book That Still Beats the Market (Little Books. Big Profits) . He defines Return on Capital as follows:
EBIT stands for Earnings Before Interest and Taxes.
Fixed Assets are also known as non-current assets. They include the Property, Plant and Equipment that the firm needs in its operation.
GuruFocus calculates net working capital as: (Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Deferred Revenue + Other Current Liabilities). We're trying to account for OPERATING assets and liabilities (part of daily business) when calculating working capital. Cash and marketable securities are considered NON-OPERATING assets and are not included in calculation. We will also back out all interest bearing debt, short term debt and the portion of long term debt that is due in the current period from the current liabilities. This debt will be considered when computing cost of capital and it would be inappropriate to count it twice.
Note:
The EBIT data used here is four times the quarterly (Jun. 2026) EBIT data.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a ROC (Joel Greenblatt) % of 28.69% mean?
Indo Amines (NSE:INDOAMIN) has a ROC (Joel Greenblatt) % of 28.69% as of Jun. 2026. Joel Greenblatt's return on capital is the ratio of EBIT to average fixed assets and net working capital. View historical data on Indo Amines and its competitors. This is 42% above median its historical median of 20.14. Over the past decade, Indo Amines' ROC (Joel Greenblatt) % has ranged from 12.68 to 39.37. According to the industry distribution chart, Indo Amines ranks #399 out of 1609 companies in the Chemicals industry, placing it in the top 24.8%.
Is Indo Amines' ROC (Joel Greenblatt) % too high?
Indo Amines' current ROC (Joel Greenblatt) % of 28.69% is 42% above median its 10-year median of 20.14. Over the past 10 years, this metric has ranged from a low of 12.68 to a high of 39.37. The Chemicals industry median ROC (Joel Greenblatt) % is 10.55. Indo Amines' value of 28.69% is 171.9% above this industry median. Based on the distribution chart, Indo Amines ranks #399 out of 1609 companies in the Chemicals industry, which is in the top quartile — a strong position relative to peers. Overall, Indo Amines has a GF Score™ of 92/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Indo Amines' ROC (Joel Greenblatt) % compare to DOW?
According to the Chemicals industry distribution chart, Indo Amines ranks #399 out of 1609 companies for ROC (Joel Greenblatt) %. This places Indo Amines in the top 25% of its industry — outperforming the majority of peers. The industry median ROC (Joel Greenblatt) % is 10.55. Indo Amines' value of 28.69% is 171.9% above this benchmark. Historically, Indo Amines' own ROC (Joel Greenblatt) % has ranged from 12.68 to 39.37 over the past decade. While the company's 10-year median is 20.14 vs. the industry median of 10.55, Indo Amines has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROC (Joel Greenblatt) % for a Chemicals company?
The median ROC (Joel Greenblatt) % among Chemicals companies is 10.55, based on 1,609 companies in the industry. Companies in the top quartile (top 25%) have a ROC (Joel Greenblatt) % significantly above this median, while those in the bottom quartile fall well below. However, ROC (Joel Greenblatt) % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Indo Amines's current ROC (Joel Greenblatt) % of 28.69% is 171.9% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROC (Joel Greenblatt) % mean?
A high ROC (Joel Greenblatt) % can signal that a stock is expensive relative to its fundamentals. Joel Greenblatt's return on capital is the ratio of EBIT to average fixed assets and net working capital. View historical data on Indo Amines and its competitors. For the Chemicals industry, the median ROC (Joel Greenblatt) % is 10.55 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Indo Amines's current ROC (Joel Greenblatt) % is 28.69%, which is 42% above median its own 10-year median of 20.14. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Indo Amines stock overvalued right now?
Based on GuruFocus' analysis, Indo Amines (NSE:INDOAMIN) is currently considered Modestly Undervalued. The stock's GF Value™ is ₹157.09, compared to a current price of ₹122.35 — trading 22.1% below its estimated fair value. The current ROC (Joel Greenblatt) % is 28.69%, which is 42% above median its 10-year median of 20.14 and 171.9% above the Chemicals industry median of 10.55. Indo Amines' overall GF Score™ is 92/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROC (Joel Greenblatt) % calculated?
ROC (Joel Greenblatt) % is calculated from a company's financial statements. For Indo Amines (NSE:INDOAMIN), the current ROC (Joel Greenblatt) % is 28.69% as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Indo Amines (NSE:INDOAMIN) Overvalued in 2026?
Based on GuruFocus' analysis, Indo Amines stock appears to be undervalued.
The current stock price of ₹122.35 is trading 22.1% below its estimated GF Value™ of ₹157.09.
GuruFocus considers Indo Amines to be Modestly Undervalued.
Key valuation signals for NSE:INDOAMIN:
ROC (Joel Greenblatt) %: 28.69% (42% above median its 10-year median of 20.14)
GF Value™: ₹157.09 vs. price of ₹122.35 (22.1% below fair value)
Industry Position: 171.9% above the Chemicals median (#399 of 1609)
No single metric tells the full story. See the NSE:INDOAMIN stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Indo Amines Ltd is a manufacturer of organic and inorganic chemical compounds. The company manufactures, develops, and supplies fine chemicals, specialty chemicals, performance chemicals, perfumery chemicals, and others that have applications in agrochemicals, pharmaceuticals, high-performance polymers, paints, pigments, printing inks, rubber chemicals, and other industries. Its only operating segment is the manufacturing of chemicals. Geographically, the company derives maximum revenue from its customers in India and the rest from outside India.
92GF Score
Get the complete analysis for NSE:INDOAMIN
ROC (Joel Greenblatt) % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:INDOAMIN has been successfully added to your 
